I objected to the drugs coming into this case. I felt (the drugs) were irrelevant.

Our view is that the pharmacy benefit is an extraordinarily good benefit. Many of these drugs cost more than $100 at retail for a month's supply. Virtually all of our members will be paying between $10 and $15.

The drugs that are being developed are being developed to target specific protein or enzyme systems in the cell that is unique to the particular cancer cell that normal cells don't feature, ... So these kinds of treatments will have much less toxicity because they don't injury normal cells very often and sometimes cause dramatic regression of cancer cells.

I used to have a drug problem, now I make enough money.

They found out it was more profitable than selling drugs -- and a lot less dangerous too.

The pipeline is terrific, ... They've probably got the strongest, best, broadest band of drugs for sale today and in the future. And remember, if you think back to the early 1990s when health-care reform was a big deal, nobody wanted to buy these drug stocks. And if you had bought them, you made a lot of money and we think the same thing is going on with some of the Medicare reform today.